ArticleThe Journal of clinical investigation2021

DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.

Xiao-Yan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.